Press Releases

11.12.15
OpGen Reports Third Quarter Financial Results and Provides Business Update
11.04.15
OpGen, Inc. Announces Timing for Third Quarter Financial Results and Conference Call
10.12.15
Data Show “Super Bug” Surveillance System Based on OpGen’s Acuitas(R) Resistome Test Can Identify Potential Outbreaks in Hospitals and Improve Infection Control  
09.22.15
OpGen to Present Data Showing Acuitas(R) Tests are Effective Tools for Investigating Transmission of "Super Bugs"
08.13.15
OpGen Reports Second Quarter Financial Results and Provides Business Update
08.05.15
OpGen, Inc. Announces Timing for Second Quarter Financial Results and Conference Call
07.14.15
OpGen to Acquire AdvanDx, Inc.
07.14.15
OpGen Closes $6 Million Financing With Merck GHI to Expand Infectious Disease Diagnostic Testing Capabilities
07.13.15
Fluidigm and OpGen Enter Into Strategic Agreement to Develop Multi-Drug Resistance Testing Kits and Equipment
06.17.15
OpGen Reports First Quarter Financial Results and Provides Business Update